BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 9869020)

  • 1. Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma.
    Porcu P; Nichols CR
    Curr Probl Cancer; 1998; 22(5):283-368. PubMed ID: 9869020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New REAL clinical entities.
    Fisher RI; Miller TP; Grogan TM
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
    Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
    Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hodgkin's lymphoma.
    Smith MR
    Curr Probl Cancer; 1996; 20(1):6-77. PubMed ID: 8919170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical (IHC) Analysis of Non-Hodgkin's Lymphoma (NHL) Spectrum According to WHO/REAL Classification: A Single Centre Experience from Punjab, India.
    Sharma M; Mannan R; Madhukar M; Navani S; Manjari M; Bhasin TS; Gill KS
    J Clin Diagn Res; 2014 Jan; 8(1):46-9. PubMed ID: 24596721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
    Mann G; Attarbaschi A; Burkhardt B; Niggli F; Klapper W; Ludwig WD; Schrappe M; Zimmermann M; Gadner H; Reiter A;
    Br J Haematol; 2007 Nov; 139(3):443-9. PubMed ID: 17868047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
    Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications.
    Naresh KN; Srinivas V; Soman CS
    Ann Oncol; 2000; 11 Suppl 1():63-7. PubMed ID: 10707782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?
    Ferrucci PF; Zucca E
    Br J Haematol; 2007 Feb; 136(4):521-38. PubMed ID: 17156403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Hodgkin's lymphoma.
    Greiner TC; Medeiros LJ; Jaffe ES
    Cancer; 1995 Jan; 75(1 Suppl):370-80. PubMed ID: 8001008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue.
    Cohen SM; Petryk M; Varma M; Kozuch PS; Ames ED; Grossbard ML
    Oncologist; 2006; 11(10):1100-17. PubMed ID: 17110630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
    Krivolapov IuA
    Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
    d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
    J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of rare forms of lymphoma.
    Zucca E; Bertoni F; Roggero E; Cavalli F
    Curr Opin Oncol; 1998 Sep; 10(5):377-84. PubMed ID: 9800105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and clinicopathologic characteristics of non-Hodgkin's lymphoma in India: a study of 935 cases using WHO classification of lymphoid neoplasms (2000).
    Sahni CS; Desai SB
    Leuk Lymphoma; 2007 Jan; 48(1):122-33. PubMed ID: 17325856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
    J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary malignant lymphoma of the intestine: clinicopathologic and immunohistochemical studies of 39 cases.
    Kojima M; Nakamura S; Kurabayashi Y; Shimizu K; Hosomura Y; Ohno Y; Itoh H; Yoshida K; Sano T; Sakurai S
    Pathol Int; 1995 Feb; 45(2):123-30. PubMed ID: 7742924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
    Andrews CN; John Gill M; Urbanski SJ; Stewart D; Perini R; Beck P
    Am J Gastroenterol; 2008 Jul; 103(7):1762-9. PubMed ID: 18557717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.